A carregar...
Sodium–glucose cotransporter 2 inhibitor‐induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction
The number of patients receiving sodium–glucose cotransporter 2 inhibitors (SGLT2is), especially those with heart failure, is increasing worldwide. SGLT2is control glycaemia by triggering glycosuria with simultaneous facilitation of a more ketogenic metabolic profile. Patients therefore are more pro...
Na minha lista:
| Publicado no: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8318418/ https://ncbi.nlm.nih.gov/pubmed/34102028 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13452 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|